April 3, 2011
An MS Patient’s determination has helped him to “Take Steps” again…
- /
- /
Published by Stuart on 4-3-11 Jarod’s Profile: MS diagnosis 1986 No MS drugs since 2007 Organic vegetarian since 2009 walking…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
April 3, 2011
THREE varying MS Patient Stories
- /
Jaxson de Ville Travels to Seattle to Help Fellow NFL Mascot First Coast News Curtis Dvorak, the man who has…
March 30, 2011
Neurologists Anticipate Increased Use of Novartis’ Gilenya and Biogen Idec’s Tysabri over the Next Six Months Despite Safety Concerns Surrounding Both Products
- /
- /
- /
- /
March 30, 2011 EXTON, Pa.–(BUSINESS WIRE)–Physician trial and market share of Novartis’ Gilenya, the first oral disease modifying agent (DMA)…
March 30, 2011
Stem Cells From Placentas Show Potential in Treating Heart Disease, Multiple Sclerosis, and More
- /
- /
BY NEAL UNGERLEIDERTue Mar 29, 2011 An Israeli biotechnology firm is betting that stem cells harvested from human placentas can help…
March 29, 2011
Potential New Treatment for Multiple Sclerosis
- /
RedOrbit.com Posted on: Tuesday, 29 March 2011, (Ivanhoe Newswire) – Multiple Sclerosis (MS) is a common, and usually disabling autoimmune…
March 29, 2011
Report Identifies Cluster areas for MS in Ohio
- /
Wellington has been designated as a disease cluster area for multiple sclerosis, according to a report released yesterday by the…
March 29, 2011
The ‘MS Views & News’ – Online Charity Auction Series
- /
- /
March 29. 2011 Dear Friends, As you know, MS Views and News, Inc. is dedicated to the global collection and…
March 27, 2011
Down and Dirty to raise money at the annual Mud Run MS in Jacksonville
- /
- /
March 26, 2011 – By Matt Soergel There comes a time in every Mud Run when simply splashing through thick brown…
March 26, 2011
Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting
- /
- /
- /
THE WOODLANDS, Texas (March 23, 2011) – Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis…
March 26, 2011
Novartis’s Gilenya MS Pill to Cost EU22,000 a Year in Germany
- /
- /
By Eva von Schaper – Mar 25, 2011 Novartis AG (NOVN)’s multiple sclerosis pill Gilenya will cost 1,850 euros ($2,620) a month in…
